Qubit Pharmaceuticals
Qubit Pharmaceuticals accelerates drug discovery through molecular simulation powered by hybrid HPC and quantum computing. Spun out of research at Sorbonne University, CNRS, and CNAM, the company's Atlas platform models molecular interactions at quantum-level accuracy, and has demonstrated a practical path to quantum utility in drug discovery by 2028.[1]
- Founded:
- Country: France
- Type: software
- Headquarters: Paris, France
- Employees: 60+
- Funding: EUR 25M+
- drug-discovery
- molecular-simulation
- hybrid-quantum-classical
- HPC
What does Qubit Pharmaceuticals do?
Qubit Pharmaceuticals accelerates drug discovery through molecular simulation powered by hybrid HPC and quantum computing. Spun out of research at Sorbonne University, CNRS, and CNAM, the company's Atlas platform models molecular interactions at quantum-level accuracy, and has demonstrated a practical path to quantum utility in drug discovery by 2028.
Where is Qubit Pharmaceuticals based?
Qubit Pharmaceuticals is headquartered in Paris, France, in the European quantum computing ecosystem.
Visit Qubit Pharmaceuticals
Frequently Asked Questions
What does Qubit Pharmaceuticals do?
Qubit Pharmaceuticals accelerates drug discovery through molecular simulation powered by hybrid HPC and quantum computing. Spun out of research at Sorbonne University, CNRS, and CNAM, the company's Atlas platform models molecular interactions at quantum-level accuracy, and has demonstrated a practical path to quantum utility in drug discovery by 2028.
Where is Qubit Pharmaceuticals based?
Qubit Pharmaceuticals is based in Paris, France.
When was Qubit Pharmaceuticals founded?
Qubit Pharmaceuticals was founded in 2020.
Sources
- "Qubit Pharmaceuticals Official Website", accessed 2026-03-19 — qubit-pharmaceuticals.com
- "Qubit Pharmaceuticals Announces Dual Breakthroughs: Quantum Speedup and 2028 Utility Path for Drug Discovery", accessed 2026-03-19 — Press Release